Amplification Studies of MET and Cdk6 in a Rat Endometrial Tumor Model and Their Correlation to Human Type I Endometrial Carcinoma Tumors

  • Emma Samuelson
  • Carola Nordlander
  • Göran Levan
  • Afrouz Behboudi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 617)


Cancer is known to be a genetic disease that is both polygenic and heterogeneous, in most cases involving changes in several genes in a stepwise fashion. The spectrum of individual genes involved in the initiation and progression of cancer is greatly influenced by genetic factors unique to each patient. A study of complex diseases such as cancer is complicated by the genetic heterogeneous background and environmental factors in the human population. Endometrial cancer (EC) is ranked fourth among invasive tumors in women. In Sweden, approximately 1300 women (27/100,000 women) are diagnosed annually. To be able to study the genetic alterations in cancer, the use of an animal model is very convenient. Females of the BDII strain are genetically predisposed to EC and 90% of female BDII rats develop EC during their lifetime. Thus, BDII rats have been used to model human EC with respect to the genetics of susceptibility and of tumor development. A set of rat EC tumors was analyzed using conventional cytogenetics and comparative genome hybridization (CGH). Chromosomal aberrations, i.e., gains, were found on rat chromosome 4 (RNO4). Using FISH analysis, we concluded that the Met oncogene and Cdk6 (cyclin-dependent kinase 6) were amplified in this set of EC tumors. The data from this investigation were used to analyze a set of human endometrial tumors for amplification of Cdk6 and Met. Our preliminary data are indicative for a good correlation between our findings in the BDII rat model for EAC and the situation in human EC. These data provide strong support for the use of animal model systems for better understanding and scrutinizing of human complex disease of cancer.


Endometrial Cancer Comparative Genome Hybridization Endometrial Carcinoma Endometrial Adenocarcinoma Brown Norway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sjöling Å, Walentinsson A, Helou K, et al. (2000) A genome wide study of genetic alterations in DMBA induced rat sarcomas. Rat Genome 6:75.Google Scholar
  2. 2.
    Laes J-F, Quan X, Ravoet M, et al. (2001) Analysis of candidate genes included in the mammary cancer susceptibility 1 (Mcs1) region. Mamm Genome 12:199–206.PubMedCrossRefGoogle Scholar
  3. 3.
    Helou K, Walentinsson A, Beckmann B, et al. (2001) Analysis of genetic changes in rat endometrial carcinomas by means of comparative genome hybridization. Cancer Genet Cytogenet 127:118–127.PubMedCrossRefGoogle Scholar
  4. 4.
    Cavanagh D, Fiorica JV, Hoffman MS, et al. (1999) Adenocarcinoma of the endometrium: an institutional review. Cancer Control; JMCC 6:354–360.Google Scholar
  5. 5.
    Hamta A, Adamovic T, Helou K, et al. (2005) Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization. Cancer Genet Cytogenet 159:123–128.PubMedCrossRefGoogle Scholar
  6. 6.
    Walentinsson A, Helou K, Wallenius V, et al. (2001) Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization. Cancer Res 61:8263–8273.PubMedGoogle Scholar
  7. 7.
    Adamovic T, Trossö F, Roshani L, et al. (2005) Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinomas as revealed by combined BAC/PAC FISH analysis, chromosome painting, zoo-FISH and allelotyping analysis. Genes Chromosom Cancer 44:139–153.PubMedCrossRefGoogle Scholar
  8. 8.
    Andersson L, Archibald A, Ashburner M, et al. (1996) Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome 7:717–734.PubMedCrossRefGoogle Scholar
  9. 9.
    Lim J, Mansukhani M, Weinstein I (2005) Proc Natl Acad Sci USA 14:5156–5161.CrossRefGoogle Scholar
  10. 10.
    Costello JF, Plass C, Arap W, et al. (1997) Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res 57:1250–1254.PubMedGoogle Scholar
  11. 11.
    Hirai Y, Utsugi K, Takeshima N, et al. (2004) Putative gene loci associated with carcinogenesis and metastasis of endocervial adenocarcinomas of uterus determined by conventional and array-based CGH. Am J Obstet Gynecol 191:1173–1182.PubMedCrossRefGoogle Scholar
  12. 12.
    Wullich B, Muller HW, Fischer U, et al. (1993) Amplified met gene linked to double minutes in human glioblastoma. Eur J Cancer 29A:1991–1995.PubMedCrossRefGoogle Scholar
  13. 13.
    Wullich B, Sattler HP, Fischer U, et al. (1994) Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14:577–579.PubMedGoogle Scholar
  14. 14.
    Nakajima M, Sawada H, Yamada Y, et al. (1999) The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85:1894–1902.PubMedGoogle Scholar
  15. 15.
    Karlsson A, Helou K, Walentinsson A, et al. (2001) Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Gene Chromosome Cancer 31:345–356.CrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Emma Samuelson
    • 1
  • Carola Nordlander
    • 2
  • Göran Levan
  • Afrouz Behboudi
  1. 1.Sahlgrenska Academy Department of Clinical GeneticsGöteborg UniversityGöteborgSweden
  2. 2.Department of Cellular and Molecular Biology-GeneticsLundberg InstituteGöteborgSweden

Personalised recommendations